Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Ascendis Pharma A/S (ASND) vs BioMarin Pharmaceutical Inc. (BMRN)

Ascendis Pharma A/S and BioMarin Pharmaceutical Inc. are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $15.7B against $12.0B — 1.3× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 159×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 11.2%. Ascendis Pharma A/S has the higher net margin (71.2% vs 2.14%) and the higher return on invested capital (15.1% vs 0.97%). Across the 22 metrics below, Ascendis Pharma A/S leads on 17 and BioMarin Pharmaceutical Inc. on 5.

Valuation

Metric ASND BMRN Biotechnology median
P/E 16.27 158.58 7.88
P/S 11.98 3.42 11.47
P/B 8.69 1.84 2.52
Price to free cash flow 37.46 16.08 21.16
EV/EBITDA 43.87 50.32 0.74
EV/Sales 11.63 4.39 10.73
Earnings yield 6.15% 0.63% (28.84%)
Free cash flow yield 2.67% 6.22% (23.03%)

Profitability

Metric ASND BMRN Biotechnology median
Gross margin 91.26% 76.12% 65.16%
Operating margin 24.84% 4.38% 0.00%
Net margin 71.20% 2.14% 0.00%
Free cash flow margin 31.97% 21.28% 0.00%
Return on equity 118.44% 1.18% (57.72%)
Return on assets 44.34% 0.76% (49.22%)
Return on invested capital 15.07% 0.97% 0.00%

Growth

Metric ASND BMRN Biotechnology median
Revenue growth (TTM) 125.98% 11.20% 5.64%
EPS growth (last fiscal year) 39.89% (18.55%) —
Revenue growth, 5-year CAGR 152.47% 11.60% 8.40%
Net income growth, 5-year CAGR 0.00% (16.39%) 0.00%

Health

Metric ASND BMRN Biotechnology median
Debt to equity 0.31 0.66 0.00
Current ratio 2.99 2.39 4.73
Net debt to EBITDA (2.16) (1.99) 0.96

Dividend

Metric ASND BMRN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ASND BMRN Biotechnology median
Market cap 15.68b 11.96b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack